Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
8 Republican senators may kill Trump’s entire bill as Thune desperately tries to work them
8 Republican senators may kill Trump’s entire bill as Thune desperately tries to work them

Share link:In this post: Eight Republican senators may block Trump’s $4.5 trillion tax and spending bill before the July 4 deadline. Senators Thom Tillis and Rand Paul have already voted no and show no signs of flipping. John Thune must secure nearly all remaining GOP votes, with a tie-breaker from VP JD Vance.

Cryptopolitan·2025/06/30 00:32
Lazarus Group strikes again in $3.2M Solana heist
Lazarus Group strikes again in $3.2M Solana heist

Share link:In this post: The Lazarus Group allegedly drained $3.2 million from multiple Solana wallets on May 16, 2025, then bridged the stolen assets to Ethereum before laundering them. On June 25 and June 27, the attackers deposited tranches of 400 ETH (roughly $1.6 million total) into Tornado Cash to obscure the trail. Approximately $1.25 million remains parked at the Ethereum address “0xa5…d528” in DAI and ETH.

Cryptopolitan·2025/06/30 00:32
Traders have gotten many things wrong in 2025, as they try to make sense of Trump
Traders have gotten many things wrong in 2025, as they try to make sense of Trump

Share link:In this post: Wall Street predictions for 2025 failed as Trump’s tariffs and policies created unexpected market chaos. The US dollar saw its worst start since 2005, defying expectations of continued strength. US stocks crashed and rebounded after Trump paused some of the highest tariffs in April.

Cryptopolitan·2025/06/30 00:32
Flash
20:57
US Dollar Index Falls 0.09% on 16th
The US Dollar Index fell 0.09% on the 16th, closing at 99.540 in the foreign exchange market.
20:48
According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a tiered royalty structure.
The document further clarifies the conditions and specific terms that trigger payment. Milestone payments will be distributed in phases based on the progress of R&D in the collaborative project, regulatory approvals, and commercialization outcomes at different stages. Tiered royalties mean that as product sales reach different thresholds, the rates will be adjusted accordingly, providing both parties with a more flexible revenue-sharing mechanism. This financial arrangement highlights both parties' confidence in the project's prospects and reflects the risk-sharing and profit-sharing models commonly seen in the biopharmaceutical industry. Although the details of the agreement have not been fully disclosed, the total potential revenue of up to $320 million undoubtedly injects strong financial momentum into the subsequent development of the project.
20:48
According to a filing submitted to the U.S. Securities and Exchange Commission, biotechnology company Arvinas Holding Company LLC, pharmaceutical giant Pfizer, and Rigel Pharmaceuticals obtained approval under the Hart–Scott–Rodino Antitrust Improvements Act on June 11, 2026.
This key development has removed regulatory obstacles for all parties to advance the previously announced licensing agreement. The conclusion of this agreement marks a new substantive phase in the related cooperation. Passing the HSR antitrust review is a crucial step in strategic collaborations involving intellectual property and market access. This usually means that regulatory authorities have determined the transaction will not materially harm competition in the relevant market. With this regulatory threshold crossed, all parties are expected to accelerate implementation of the detailed terms of the licensing agreement, boosting progress in related R&D or commercialization projects. This dynamic is being closely watched by industry observers.
News